Retour
Fourchette du Jour
35,00 €
35,97 €
Fourchette 52 Semaines
21,00 €
37,25 €
Volume
145
Moyenne 50J / 200J
36,67 €
/
33,88 €
Clôture Précédente
35,97 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 123,8 | 0,4 |
| P/B | 5,0 | 2,9 |
| ROE % | 3,8 | 3,7 |
| Net Margin % | 2,9 | 3,8 |
| Rev Growth 5Y % | 4,0 | 10,0 |
| D/E | 0,6 | 0,2 |
Points Clés
Revenue grew 4,04% annually over 5 years — modest growth
Earnings grew 144,30% over the past year
ROE of 3,77% is below average
Generating 48,60M in free cash flow
P/E of 123,76 — premium valuation
PEG of 0,60 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
4,04%
Revenue (1Y)0,60%
Earnings (1Y)144,30%
FCF Growth (3Y)78,81%
Qualité
Return on Equity
3,77%
ROIC4,29%
Net Margin2,87%
Op. Margin6,30%
Sécurité
Debt / Equity
0,56
Current Ratio1,94
Interest Coverage2,07
Valorisation
P/E Ratio
123,76
P/B Ratio5,02
EV/EBITDA61,47
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,60% | Revenue Growth (3Y) | -1,23% |
| Earnings Growth (1Y) | 144,30% | Earnings Growth (3Y) | -23,87% |
| Revenue Growth (5Y) | 4,04% | Earnings Growth (5Y) | -20,08% |
| Profitability | |||
| Revenue (TTM) | 672,80M | Net Income (TTM) | 19,30M |
| ROE | 3,77% | ROA | 2,15% |
| Gross Margin | 100,00% | Operating Margin | 6,30% |
| Net Margin | 2,87% | Free Cash Flow (TTM) | 48,60M |
| ROIC | 4,29% | FCF Growth (3Y) | 78,81% |
| Safety | |||
| Debt / Equity | 0,56 | Current Ratio | 1,94 |
| Interest Coverage | 2,07 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 123,76 | P/B Ratio | 5,02 |
| P/S Ratio | 3,55 | PEG Ratio | 0,60 |
| EV/EBITDA | 61,47 | Dividend Yield | 0,02% |
| Market Cap | 2,39B | Enterprise Value | 2,61B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 672,80M | 668,80M | 689,70M | 593,40M | 574,30M |
| Net Income | 19,30M | 7,90M | 33,30M | 40,90M | 47,30M |
| EPS (Diluted) | 0,25 | 0,12 | 0,50 | 0,62 | 0,72 |
| Gross Profit | 672,80M | 178,70M | 239,30M | 226,00M | 232,20M |
| Operating Income | 42,40M | 6,40M | 40,50M | 56,60M | 61,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 899,00M | 1,03B | 1,01B | 1,02B | 851,00M |
| Total Liabilities | 423,00M | 485,00M | 440,30M | 445,80M | 354,40M |
| Shareholders' Equity | 475,60M | 548,20M | 569,40M | 578,50M | 498,10M |
| Total Debt | 265,90M | 291,20M | 232,10M | 223,80M | 151,60M |
| Cash & Equivalents | 48,00M | 42,50M | 36,30M | 38,80M | 46,00M |
| Current Assets | 254,40M | 271,10M | 259,00M | 257,50M | 231,70M |
| Current Liabilities | 131,30M | 150,60M | 147,20M | 151,30M | 142,50M |